These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33392498)

  • 21. Long-Lasting
    Bazraee S; Mobedi H; Mashak A; Jamshidi A
    Curr Drug Deliv; 2022; 19(1):157-166. PubMed ID: 34139983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silica particles incorporated into PLGA-based in situ-forming implants exploit the dual advantage of sustained release and particulate delivery.
    Thalhauser S; Peterhoff D; Wagner R; Breunig M
    Eur J Pharm Biopharm; 2020 Nov; 156():1-10. PubMed ID: 32860903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant Pharmacokinetics.
    Joiner JB; King JL; Shrivastava R; Howard SA; Cottrell ML; Kashuba ADM; Dayton PA; Benhabbour SR
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial Leuprolide Acetate Release from Poly(d,l-lactide-
    Li Z; Mu H; Larsen SW; Jensen H; Østergaard J
    Mol Pharm; 2020 Dec; 17(12):4522-4532. PubMed ID: 33164519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An in vitro gel-based system for characterizing and predicting the long-term performance of PLGA in situ forming implants.
    Li Z; Mu H; Weng Larsen S; Jensen H; Østergaard J
    Int J Pharm; 2021 Nov; 609():121183. PubMed ID: 34653562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of implants for sustained release of 5-fluorouracil using low molecular weight biodegradable polymers.
    Hanafy AF; El-Egaky AM; Mortada SA; Molokhia AM
    Drug Discov Ther; 2009 Dec; 3(6):287-95. PubMed ID: 22495663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
    Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
    J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical effect of ultrasound-guided injection of biodegradable poly(lactic-co-glycolic acid)-Fe
    Liang B; Zuo GQ; Zheng YY; He S; Zuo DY
    Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):911-915. PubMed ID: 28073412
    [No Abstract]   [Full Text] [Related]  

  • 29. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
    Wang SH; Liang ZH; Zeng S
    Int J Pharm; 2007 Jun; 337(1-2):102-8. PubMed ID: 17296274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gentamicin Eluting 3D-Printed Implants for Preventing Post-Surgical Infections in Bone Fractures.
    Poudel I; Annaji M; Zhang C; Panizzi PR; Arnold RD; Kaddoumi A; Amin RH; Lee S; Shamsaei N; Babu RJ
    Mol Pharm; 2023 Aug; 20(8):4236-4255. PubMed ID: 37455392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins.
    Desai KG; Olsen KF; Mallery SR; Stoner GD; Schwendeman SP
    Pharm Res; 2010 Apr; 27(4):628-43. PubMed ID: 20148292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monodispersed Sirolimus-Loaded PLGA Microspheres with a Controlled Degree of Drug-Polymer Phase Separation for Drug-Coated Implantable Medical Devices and Subcutaneous Injection.
    Zhang Z; Ekanem EE; Nakajima M; Bolognesi G; Vladisavljević GT
    ACS Appl Bio Mater; 2022 Aug; 5(8):3766-3777. PubMed ID: 35848106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery.
    Benhabbour SR; Kovarova M; Jones C; Copeland DJ; Shrivastava R; Swanson MD; Sykes C; Ho PT; Cottrell ML; Sridharan A; Fix SM; Thayer O; Long JM; Hazuda DJ; Dayton PA; Mumper RJ; Kashuba ADM; Victor Garcia J
    Nat Commun; 2019 Sep; 10(1):4324. PubMed ID: 31541085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
    Desai KG; Mallery SR; Schwendeman SP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of depot PLGA-based
    Gomaa E; Eissa NG; Ibrahim TM; El-Bassossy HM; El-Nahas HM; Ayoub MM
    Saudi Pharm J; 2023 Apr; 31(4):499-509. PubMed ID: 37063437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.
    Mosafer J; Teymouri M
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards the optimization of drug delivery to the cochlear apex: Influence of polymer and drug selection in biodegradable intracochlear implants.
    Lehner E; Honeder C; Knolle W; Binder W; Scheffler J; Plontke SK; Liebau A; Mäder K
    Int J Pharm; 2023 Aug; 643():123268. PubMed ID: 37488058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pro-angiogenic degradable Mg-poly(lactic-co-glycolic acid) implant combined with rhbFGF in a rat limb ischemia model.
    Bao H; Lv F; Liu T
    Acta Biomater; 2017 Dec; 64():279-289. PubMed ID: 28951330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen.
    Clark A; Milbrandt TA; Hilt JZ; Puleo DA
    Acta Biomater; 2014 May; 10(5):2125-32. PubMed ID: 24424269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.